
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7131F89B72E431C131F0029DF0E65.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="biomres">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Biomaterials Research">
<meta name="citation_title" content="Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy">
<meta name="citation_author" content="Qiyue Wang">
<meta name="citation_author_institution" content="School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_author_institution" content="NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China.">
<meta name="citation_author" content="Zixu Cui">
<meta name="citation_author_institution" content="School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_author" content="Chenguang Guo">
<meta name="citation_author_institution" content="School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_author" content="Yue Zhang">
<meta name="citation_author_institution" content="School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_author" content="Jinhua Chen">
<meta name="citation_author_institution" content="NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China.">
<meta name="citation_author_institution" content="Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.">
<meta name="citation_author" content="Ruitao Zhang">
<meta name="citation_author_institution" content="NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China.">
<meta name="citation_author_institution" content="Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.">
<meta name="citation_author" content="Xueming Li">
<meta name="citation_author_institution" content="School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_author" content="Zhengjie Meng">
<meta name="citation_author_institution" content="College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_author" content="Hao Ren">
<meta name="citation_author_institution" content="School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="29">
<meta name="citation_firstpage" content="0237">
<meta name="citation_doi" content="10.34133/bmr.0237">
<meta name="citation_pmid" content="40785845">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/pdf/bmr.0237.pdf">
<meta name="description" content="The management of medulloblastoma (MB) remains a significant challenge, primarily attributed to the presence of cancer stem cells and the inadequate delivery of therapeutic agents across the blood–brain barrier. GLI, as a regulator of the hedgehog ...">
<meta name="og:title" content="Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The management of medulloblastoma (MB) remains a significant challenge, primarily attributed to the presence of cancer stem cells and the inadequate delivery of therapeutic agents across the blood–brain barrier. GLI, as a regulator of the hedgehog ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332260">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.34133/bmr.0237"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/bmr.0237.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332260%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332260/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332260/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-biomres.png" alt="Biomaterials Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Biomaterials Research" title="Link to Biomaterials Research" shape="default" href="https://spj.science.org/journal/bmr" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Biomater Res</button></div>. 2025 Aug 8;29:0237. doi: <a href="https://doi.org/10.34133/bmr.0237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.34133/bmr.0237</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Biomater%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biomater%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Biomater%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Biomater%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Qiyue Wang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Qiyue Wang</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">
<sup><sup>2</sup></sup>NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, 
China Pharmaceutical University, Nanjing 210009, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qiyue Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cui%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Zixu Cui</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Zixu Cui</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cui%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zixu Cui</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chenguang Guo</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chenguang Guo</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chenguang Guo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yue Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yue Zhang</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yue Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jinhua Chen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jinhua Chen</span></h3>
<div class="p">
<sup><sup>2</sup></sup>NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, 
China Pharmaceutical University, Nanjing 210009, China.</div>
<div class="p">
<sup><sup>3</sup></sup>Department of Pharmaceutics, School of Pharmacy, 
China Pharmaceutical University, Nanjing 211198, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinhua Chen</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ruitao Zhang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ruitao Zhang</span></h3>
<div class="p">
<sup><sup>2</sup></sup>NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, 
China Pharmaceutical University, Nanjing 210009, China.</div>
<div class="p">
<sup><sup>3</sup></sup>Department of Pharmaceutics, School of Pharmacy, 
China Pharmaceutical University, Nanjing 211198, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruitao Zhang</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Xueming Li</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Xueming Li</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xueming Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meng%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Zhengjie Meng</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Zhengjie Meng</span></h3>
<div class="p">
<sup><sup>4</sup></sup>College of Biotechnology and Pharmaceutical Engineering, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meng%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhengjie Meng</span></a>
</div>
</div>
<sup>4,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ren%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Hao Ren</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Hao Ren</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ren%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hao Ren</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>School of Pharmaceutical Science, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div id="aff2">
<sup><sup>2</sup></sup>NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, 
China Pharmaceutical University, Nanjing 210009, China.</div>
<div id="aff3">
<sup><sup>3</sup></sup>Department of Pharmaceutics, School of Pharmacy, 
China Pharmaceutical University, Nanjing 211198, China.</div>
<div id="aff4">
<sup><sup>4</sup></sup>College of Biotechnology and Pharmaceutical Engineering, 
Nanjing Tech University, Nanjing 211816, China.</div>
<div class="author-notes p"><div class="fn" id="corr1">
<sup>*</sup><p class="display-inline">Address correspondence to: <span>qiyue.wang@njtech.edu.cn</span> (Q.W.); <span>mengjames@njtech.edu.cn</span> (Z.M.); <span>hren@njtech.edu.cn</span> (H.R.)</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 27; Revised 2025 Jul 9; Accepted 2025 Jul 11; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 Qiyue Wang et al.</div>
<p>Exclusive licensee Korean Society for Biomaterials, Republic of Korea. No claim to original U.S. Government Works. Distributed under a <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License (CC BY 4.0)</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332260  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40785845/" class="usa-link">40785845</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The management of medulloblastoma (MB) remains a significant challenge, primarily attributed to the presence of cancer stem cells and the inadequate delivery of therapeutic agents across the blood–brain barrier. GLI, as a regulator of the hedgehog signaling pathway in normal cerebellum development, also exerts pivotal functions in MB initiation, progression, and metastasis and maintains the stemness of MB stem cells. In this study, we devised a combined therapeutic approach by integrating the BRD4 inhibitor JQ1 with the SMO inhibitor saikosaponin B1 (SSB1) to inhibit MB via regulation of GLI activation. The results suggested that JQ1 and SSB1 synergistically inhibited MB proliferation, constricted MB metastasis, and down-regulated stem cell phenotypes via reduced GLI and MYC expression. Tryptamine-derived lipid nanoparticles (NPs) transported JQ1 and SSB1 to MB tissues. The targeted NPs demonstrated prolonged drug release kinetics and significantly improved their accumulation in MB tumors. Systemic administration of drug-loaded targeted NPs significantly decreased tumor burden without hepatic toxicity in xenograft MB-bearing mice. The combination of JQ1 and SSB1 presents an innovative therapeutic paradigm for suppressing MB proliferation, recurrence, and metastasis, with the potential to drive the development of novel MB treatment strategies in the future.</p></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Medulloblastoma (MB) is one of the most common malignant tumors in the cerebella of children [<a href="#B1" class="usa-link" aria-describedby="B1">1</a>]. Current MB treatment includes surgery and a high dose of radiation followed by chemotherapy [<a href="#B2" class="usa-link" aria-describedby="B2">2</a>]. Despite recent advances, over 30% of children die from MB, and 30% suffer from tumor recurrence [<a href="#B3" class="usa-link" aria-describedby="B3">3</a>–<a href="#B5" class="usa-link" aria-describedby="B5">5</a>]. Most survivors are left with endocrine disorders and lifelong neurocognitive sequelae because of the neurotoxicity associated with radiation and chemotherapeutic drugs. Therefore, more accurate and effective therapeutic strategies against MB with minimal toxicity are urgently needed to improve the patient’s survival.</p>
<p>Whole-genome sequencing and gene copy number analysis have enabled the classification of MB into 4 major subtypes: wingless/integrated, sonic hedgehog (SHH), group 3, and group 4 [<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>]. Almost 30% of all patients with MB belong to the SHH group characterized by the activation of the hedgehog (Hh) signaling pathway, and 25% belong to the group 3 subtype with <em>MYC</em> gene amplification. The activation of GLI1, 1 of 3 isoforms, is often considered a readout of Hh pathway activation, regulating genes such as <em>MYCN</em>, <em>CYCLIN D</em>, and <em>BCL2</em> to control tumor progression [<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B9" class="usa-link" aria-describedby="B9">9</a>]. Also, in the group 3 subtype, MYC as a transcription factor could regulate GLI1 expression, leading to tumor growth and relapse. Therefore, regulation of GLI1 activity is an attractive strategy for MB treatment in SHH MB and group 3 MB.</p>
<p>It has been reported that the Hh pathway regulates cancer stem cell (CSC) proliferation [<a href="#B10" class="usa-link" aria-describedby="B10">10</a>,<a href="#B11" class="usa-link" aria-describedby="B11">11</a>]. CSCs are a small population of tumor cells with self-renewal and differentiation capacity to generate tumors. In recent years, CSCs have been found in different subtypes of MB [<a href="#B12" class="usa-link" aria-describedby="B12">12</a>–<a href="#B15" class="usa-link" aria-describedby="B15">15</a>]. The stemness property of CSCs in MB allows postsurgical relapse and drug resistance. Several critical regulators have been found to contribute to CSC maintenance. Transcription factors GLI1/2 have been reported as crucial effectors to regulate stemness-related genes such as <em>MYCN</em>, <em>OCT4</em>, <em>NANOG</em>, and <em>BMI1</em> [<a href="#B12" class="usa-link" aria-describedby="B12">12</a>–<a href="#B14" class="usa-link" aria-describedby="B14">14</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>]. The metastasis of MB is also related to CSCs through the regulation of the TWIST1/BMI1 axis [<a href="#B17" class="usa-link" aria-describedby="B17">17</a>–<a href="#B20" class="usa-link" aria-describedby="B20">20</a>]. BMI1 could promote the epithelial–mesenchymal transition process with loss of cell adhesion and induce MB invasion into healthy tissues. Moreover, MB metastasis is also facilitated by matrix metalloproteinases (MMPs), such as MMP2 and MMP9, by extracellular matrix (ECM) degradation, and later, MMPs are up-regulated by BRD4/MYC and GLI [<a href="#B21" class="usa-link" aria-describedby="B21">21</a>–<a href="#B23" class="usa-link" aria-describedby="B23">23</a>]. Meanwhile, for group 3 MB, MYC could directly regulate stemness-related factors and indirectly regulate <em>GLI</em> and its downstream genes.</p>
<p>Several strategies have been developed to eliminate CSCs, such as blocking antiapoptosis pathways, maintaining the quiescence of CSCs, or disrupting the interaction between CSCs and the microenvironment [<a href="#B24" class="usa-link" aria-describedby="B24">24</a>,<a href="#B25" class="usa-link" aria-describedby="B25">25</a>]. The most effective strategies focus on target-specific signaling pathways such as the NOTCH pathway, PI3K/AKT pathway, and SHH pathway to reduce CSC frequency [<a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]. However, inhibition of SHH MB is associated with the development of chemoresistance because of mutations of <em>SMO</em> and <em>SUFU</em> [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>]. On the other hand, direct MYC inhibition has been proven to be a difficult therapeutic target, and inhibition of PI3K to enhance MYCN degradation provides only limited therapeutic benefits and leads to activation of compensatory pathways and chemoresistance [<a href="#B30" class="usa-link" aria-describedby="B30">30</a>]. These resistance mechanisms could be overcome by modulating <em>GLI</em> transcription downstream of <em>SMO</em> using JQ1, which is a BRD4 inhibitor and inhibits <em>MYC</em> expression and the proliferation of CD15<sup>+</sup> cells (CSCs).</p>
<p>Efficient transport of drugs across the blood–brain barrier (BBB) is still a considerable challenge [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>]. The BBB is a physiological barrier that regulates the entry of molecules into the brain by restricting their passive transportation [<a href="#B32" class="usa-link" aria-describedby="B32">32</a>,<a href="#B33" class="usa-link" aria-describedby="B33">33</a>]. With nanotechnology development, several delivery systems were established to improve the biodistribution of drugs in the brain [<a href="#B34" class="usa-link" aria-describedby="B34">34</a>]. Nanoplatforms have the advantages of a high loading capacity, a long circulation half-life, and reduced toxicity by providing controlled release [<a href="#B35" class="usa-link" aria-describedby="B35">35</a>,<a href="#B36" class="usa-link" aria-describedby="B36">36</a>]. Further, nanoformulations decorated by certain antibodies or protein fragments could directly access the brain through receptor-mediated endocytosis. Several targeting ligands for brain endocytosis have been reported, such as the insulin-like growth factor 1 receptor (IGF1R), transferrin receptor, and low-density lipoprotein receptor [<a href="#B37" class="usa-link" aria-describedby="B37">37</a>–<a href="#B41" class="usa-link" aria-describedby="B41">41</a>]. However, the widespread expression of these receptors in other primary tissues resulted in unintended biodistribution patterns and potential toxicity risks and limited the usage of brain-targeting delivery platforms. A targeting ligand specific to the desired organ/site could better control the distribution of nanoparticles (NPs). Some neurotransmitters, as endogenous chemicals, have been demonstrated to cross the BBB [<a href="#B42" class="usa-link" aria-describedby="B42">42</a>]. It has been reported that tryptamine (Try)-derived synthetic lipids effectively deliver drug-loaded cargo into the brain [<a href="#B43" class="usa-link" aria-describedby="B43">43</a>,<a href="#B44" class="usa-link" aria-describedby="B44">44</a>]. Even though the BBB transportation mechanism of neurotransmitter-derived carriers is still not fully understood, several investigations suggested that organic cation transporters (OCTs) might be the targeted receptors for neurotransmitters transporting into the brain. The rich expression of OCTs in the brain microvascular endothelial cells suggests their substrates, such as Try, as attractive ligands for decorated nanoplate forms targeted to the brain. Moreover, vigorous tumor metabolism facilitated the cellular uptake of nutrients, including Try, which could potentially improve MB targeting.</p>
<p>In this study, we developed a therapeutic strategy to co-deliver the BRD4 inhibitor JQ1 and the SMO inhibitor saikosaponin B1 (SSB1) (extracts from Chinese Thorowax roots) using tryptamine-derived lipid (Try-Lip) NPs for targeted MB treatment. Try-Lip NPs achieved satisfactory BBB penetration ability based on the organic cation transporter 2 (OCT2)-mediated assay. The combination of JQ1 and SSB1 efficiently reduced MB cell viability by regulating the cell cycle and apoptosis, significantly reduced CD15<sup>+</sup> MB stem cell population, and down-regulated the expression of metastasis-related factors, exhibiting significant MB progression and metastasis inhibition ability. Systemic administration of Try-derived NPs significantly improved both JQ1 and SSB1 accumulation in orthotopic MB and efficiently decreased tumor burden in vivo. Therefore, combining a BRD4 inhibitor and an SMO inhibitor appears to be a very attractive therapeutic avenue for MB treatment.</p></section><section id="sec2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="sec3"><h3 class="pmc_sec_title">Materials</h3>
<p>SSB1, GDC-0449, and JQ1 were procured from MedChemExpress (Princeton, USA). Try-Lips were synthesized in-house. DSPE-PEG<sub>2k</sub> and distearoylphosphatidylcholine (DSPC) were purchased from AVT Pharmaceutical Tech Co., Ltd. (Shanghai, China). All other chemicals and reagents were purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China).</p></section><section id="sec4"><h3 class="pmc_sec_title">Mammalian cells and animals</h3>
<p>DAOY and D341 Med cells were procured from Wuhan Pricella Biotechnology Co., Ltd. (Wuhan, China). ONS-76 cells were procured from Shanghai Yu Bo Biotech Co., Ltd. (Shanghai, China). SVG p12 cells were procured from Xiamen Immocell Biotechnology Co., Ltd. (Fujian, China). Human brain microvascular endothelial cells (HBMECs) were procured from Hefei Wanwu Biotechnology Co., Ltd. (Anhui, China). DAOY and D341 Med cell lines were maintained in Eagle’s minimum essential medium supplemented with 10% fetal bovine serum (FBS) and a 1% penicillin/streptomycin/gentamicin B cocktail. ONS-76 and SVG p12 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM), containing 10% FBS and 1% penicillin/streptomycin/gentamicin B. HBMECs were cultured in MCDB 131 medium supplemented with 10 ng/ml epidermal growth factor, 1 μg/ml hydrocortisone, 10 mM glutamine, and 10% FBS. Cells were maintained in a humidified 37 °C incubator supplemented with 5% CO<sub>2</sub> for further use. CD15<sup>+</sup> DAOY and CD15<sup>+</sup> ONS-76 cells were sorted from DAOY and ONS-76 cells using a flow cytometer after incubating with BV-650-CD15 antibody. The sorted cells were seeded onto a flask in DMEM/F12 media supplemented with 1 × N2, 0.5 × B27 without vitamin A, 10 ng/ml epidermal growth factor, and 10 ng/ml basic fibroblast growth factor and maintained at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>.</p>
<p>NSG mice at 6 to 8 weeks with random sex were procured from Shanghai Model Organisms Center, Inc. (Shanghai, China). All animal procedures were authorized by the Institutional Animal Care and Use Committee of the Animal Experiment Center at China Pharmaceutical University (Approval No. 20190515-007). All mice were kept in a specific-pathogen-free-grade facility under a 12-h light/dark cycle, at 20 ± 3 °C, and with 40% to 70% relative humidity.</p></section><section id="sec5"><h3 class="pmc_sec_title">Synthesis of Try-Lips</h3>
<p>Try-Lips were synthesized with a 4-step reaction, as shown in Fig. <a href="#supplementary-material-1" class="usa-link">S1</a>. (a) Ten grams of 2,2′-pyridine disulfide and 0.67 ml of acetic acid were mixed in methanol. A solution of undecanethiol (5.09 ml) in 15 ml of dichloromethane was added dropwise to the mixture, followed by stirring at room temperature for 3 h. The solvent in the mixture was evaporated, and compound A was purified using silicone column chromatography assay with ethyl acetate and hexane (1:9 <em>v</em>/<em>v</em> ratio) as the eluent. (b) Compound A (4.0 g) was dissolved in 50 ml of methanol with a catalytic amount of acetic acid, and 2-mercaptoethanol (2.1 g) was added dropwise, followed by a 6-h reaction at room temperature. The solvent of the mixture was evaporated, and compound B was purified using silicone column chromatography assay with a mixture of ethyl acetate and hexane (1:4 <em>v</em>/<em>v</em> ratio) as the eluent. (c) Compound B (1.3 g) was dissolved in 50 ml of dichloromethane and mixed with 1.0 ml of triethylamine. The resulting solution was cooled to 0 °C, and acryloyl chloride (0.56 g) was added dropwise. The reaction mixture was then stirred at room temperature for 4 h, followed by extraction with dichloromethane at least 3 times. The organic phases were merged and concentrated under reduced pressure. Compound C was purified using silicone column chromatography assay with a mixture of ethyl acetate and hexane (1:4 <em>v</em>/<em>v</em> ratio) as the eluent. (d) To synthesize Try-Lips, Try and compound C were mixed and heated at a 1:2.4 molar ratio at 80 °C for 48 h. The crude product was purified by silica gel column chromatography, and the structure of Try-Lip and intermediate products was characterized by <sup>1</sup>H nuclear magnetic resonance.</p></section><section id="sec6"><h3 class="pmc_sec_title">Preparation and characterization of NPs</h3>
<p>Try-derived NPs were prepared using the film hydration assay. Briefly, Try-Lips, cholesterol, DSPC, and DSPE-PEG<sub>2k</sub> at a molar ratio of 50:38.5:10:1.5 (total mass of 30 mg) were dissolved in chloroform and mixed with 1.5 mg of JQ1 and 3.0 mg of SSB1. The solvent was evaporated to form a film, followed by overnight drying in a vacuum. Then, 2 ml of PBS was added, and the mixture was sonicated in a 37 °C water bath for 10 min. The mixture was then extruded into a film with a pore size of 200 nm at least 5 times. The solution was collected for further characterization. The hydrodynamic diameter and zeta potential of the NPs were analyzed by Malvern Zetasizer. The particle morphology was evaluated using transmission electron microscopy. The drug loading (DL) and encapsulation efficiency of the formulation were measured using a high-performance liquid chromatography system (Waters Corp). The drug release behavior was analyzed by placing drug-loaded NPs (equivalent 500 μg) into a dialysis bag and suspended into 50 ml of PBS solution containing 1% <em>v</em>/<em>v</em> Tween 80. At specified time points, 1 ml of the release medium was collected, and an equal volume of fresh medium was replenished. The drug concentration in the samples was analyzed by high-performance liquid chromatography to determine the release profile. The stability of drug-loaded particles was determined by measuring the particle size at different time intervals after the formulation was prepared. The nontargeted NPs were prepared with the formulation of cholesterol, DSPC, and DSPE-PEG<sub>2k</sub> using the same assay.</p></section><section id="sec7"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p>Cells were plated into 96-well plates at a density of 3 × 10<sup>3</sup>/well containing 100 μl of the growth medium and then treated with a designated series of doses of JQ1 or SSB1 for 48 h. The cytotoxic effect of drugs was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. To determine the combination index (CI), each drug was tested individually and at fixed ratio combinations across 2-fold serial dilutions. The IC<sub>50</sub> of individual drugs and the CI value of their combination was calculated using the software COMPUSYN (CI values &lt;1 indicate synergistic effects, =1 indicate additive effects, and &gt;1 indicate antagonistic effects).</p></section><section id="sec8"><h3 class="pmc_sec_title">Colony formation assay</h3>
<p>Cells were incubated with JQ1, SSB1, or their combination at half of the IC<sub>50</sub> value for 24 h and then plated into 6-well plates at a density of 250 cells/well for 7-d culturing, subsequently. Colonies were fixed with a 4% paraformaldehyde fixative and evaluated under a microscope following the staining of viable cells with 0.5% crystal violet solution. Then, the crystal violet stain was dissolved using 1.5 ml of dilute acetic acid solution (10%, <em>v</em>/<em>v</em>), and the optical density was measured at 590 nm.</p></section><section id="sec9"><h3 class="pmc_sec_title">Cell cycle and apoptosis analysis</h3>
<p>The cell cycle analysis was performed using Cell Cycle and Apoptosis Analysis Kit (Beyotime). Briefly, cells were incubated with JQ1, SSB1, or their combination for 48 h at a concentration of half of IC<sub>50</sub>. Then, cells were harvested and fixed in 70% ethanol for 3 h, and about 1 × 10<sup>6</sup> cells from each sample were stained with propidium iodide (PI)/RNase staining solution in the dark for half an hour. Flow cytometry analysis was performed using an LSRFortessa flow cytometer (BD Biosciences) to assess the cell cycle distribution. For the apoptosis evaluation, cells were plated into 6-well plates and incubated with JQ1, SSB1, and their combination for 48 h. The cells were harvested, washed, and stained by allophycocyanin–annexin V and PI in the dark for 15 min. All stained samples were immediately analyzed by the flow cytometer (LSRFortessa, BD Biosciences).</p></section><section id="sec10"><h3 class="pmc_sec_title">Real-time polymerase chain reaction analysis</h3>
<p>To measure changes in the messenger RNA (mRNA) level, cells were treated with JQ1, SSB1, and their combination at a concentration of half of IC<sub>50</sub>. Treated cells were rinsed and lysed, followed by isolation of total RNA using RNeasy Mini Kit. The total RNA was converted to complementary DNA by a multiscribe reverse transcription kit (Applied Biosystems), and real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed using SYBR Green qPCR Master Mix on a LightCycler 480 instrument (Roche) using primers (Table <a href="#supplementary-material-1" class="usa-link">S1</a>).</p></section><section id="sec11"><h3 class="pmc_sec_title">Cell migration and invasion study</h3>
<p>Cell migration was assessed using scratch wound healing assays. Cells were plated and kept cultured to form a confluent monolayer in 6-well plates, and a scratch line was created by a 200-μl pipette tip, followed by gentle washing to remove detached cells. The monolayers were then treated with JQ1, SSB1, or their combinations at a concentration of half of IC<sub>50</sub>. Images of the scratch area were captured at 24 h post-scratching using a brightfield inverted microscope (Zeiss, Germany).</p>
<p>Cell migration was also investigated by the Boyden chamber assay. Cells were incubated with JQ1, SSB1, and their combination for 24 h with a concentration of IC<sub>50</sub> and then collected, counted, and seeded into the upper chamber of a 24-well transwell insert (3.0-μm pore size) at the same cell number (1 × 10<sup>5</sup> cells/well). After 24-h incubation with FBS-free medium, nonmigrated cells on the upper surface were gently wiped off with a cotton swab. Migrated cells on the lower membrane were fixed in 70% ethanol for 30 min, stained with 0.1% crystal violet, and imaged under a brightfield inverted microscope. Migrated cells were counted to calculate the inhibition percentage.</p>
<p>Cell invasion was determined using the Boyden chamber assay. Transwell inserts were coated with 50 μl of Matrigel and further incubated at 37 °C for 30 min to form a thin gel layer. Cells were treated with JQ1, SSB1, and their combination for 24 h with a concentration of IC<sub>50</sub> and then collected and seeded into the upper chamber of a 24-well transwell insert (3.0-μm pore size) at the same cell number (1 × 10<sup>5</sup> cells/well). After 24-h incubation, the invading cells were fixed and stained in the same way as described in the migration assay and imaged using a brightfield inverted microscope.</p></section><section id="sec12"><h3 class="pmc_sec_title">CD15<sup>+</sup> and CD133<sup>+</sup> MB stem cell analysis</h3>
<p>CD15<sup>+</sup> DAOY and CD15<sup>+</sup> ONS-76 cells were plated into 6-well plates and allowed to attach overnight. Then, cells were incubated with JQ1, SSB1, and their combination for 48 h. After incubation, cells were harvested, washed, and stained with BV650 Mouse Anti-Human CD15 and PE Anti-human CD133 Antibody, followed by analysis by flow cytometry (LSRFortessa, BD Biosciences).</p></section><section id="sec13"><h3 class="pmc_sec_title">In vitro BBB model and cellular uptake investigation</h3>
<p>The in vitro BBB penetration ability of NPs was evaluated using the transwell assay. HBMECs were plated into the transwell upper chamber for monolayer formation. The transepithelial electrical resistance was determined until a value of 200 Ω·cm<sup>2</sup> was achieved. MB cells were seeded into 6-well plates at a density of 1 × 10<sup>5</sup> cells per well and incubated overnight to allow attachment. Then, the prepared HBMEC monolayer in the transwell insert was placed on the plate, and FBS-free culture medium containing Cy5.5-labeled nontargeted NPs or Try-derived NPs with a concentration of 100 μg/ml was added in the upper chamber. The cells in plates and transwell inserts were cultured for 6 h, collected, rinsed, and analyzed by flow cytometry and confocal laser scanning microscopy (fixed and stained with 4′,6-diamidino-2-phenylindole [DAPI] and fluorescein isothiocyanate–OCT2 antibody).</p></section><section id="sec14"><h3 class="pmc_sec_title">Orthotopic MB mouse model</h3>
<p>For orthotopic MB model establishment, luciferase-expressing DAOY cells were implanted into the cerebellum area of NSG mice as described below. NSG mice were anesthetized and positioned on a stereotaxic frame, followed by exposure of the skull. A small burr hole was drilled in the skull 1 mm posterior to the lambdoid suture and 1 mm lateral to the sagittal suture over the cerebellum. A total of 10 μl of cell suspension in phosphate-buffered saline (PBS; containing 1 × 10<sup>5</sup> cells) was implanted into the cerebellum at a rate of 1 μl/min. The tumor growth was continuously monitored for 3 weeks using an IVIS imaging instrument.</p></section><section id="sec15"><h3 class="pmc_sec_title">In vivo BBB permeability of Try-derived NPs</h3>
<p>The BBB penetration ability of Try-derived NPs was assessed in both normal NSG mice and orthotopic MB NSG mice. These mice were euthanized 2 h post-intravenous injection of Cy5.5-labeled Try-derived NPs and nontargeted NPs. The brain tissues were collected, embedded using OCT, and sliced into 10-μm-thick sections on glass slides. Coverslips were mounted onto the glass slides using ProLong Gold antifade reagent containing DAPI for nuclear staining. Fluorescence images were captured with an LSM710 confocal laser scanning microscope equipped with a ×40 oil immersion objective and corresponding filters.</p></section><section id="sec16"><h3 class="pmc_sec_title">Biodistribution of NPs</h3>
<p>The biodistribution of JQ1- and SSB1-loaded Try-derived NPs and nontargeted NPs was determined in MB NSG mice. Drug-loaded NPs were injected intravenously; blood and major organs were collected at 6 and 24 h postinjection. The drug concentration in major organs was measured using liquid chromatography–tandem mass spectrometry (LC–MS/MS) (4000 QTRAP, AB, Sciex Inc.) with the following steps: Organ tissues were weighed, homogenized in 1 ml of water, and spiked with OTX-015 as an internal standard. Subsequently, 1 ml of acetonitrile was added for protein precipitation. The mixture was centrifuged, and the supernatant was evaporated to dryness at 37 °C under airflow. The residue was reconstituted with mobile phase and analyzed using LC–MS/MS assay. Shimadzu LC-20 AT furnished with an RP18 column (Xterra, Waters) was used for separation with the following conditions: mobile phase of acetonitrile:water (60:40, <em>v</em>/<em>v</em>), flow rate of 1 ml/min, and column temperature of 30 °C. LC–MS/MS data acquisition was performed by using the Analyst software, and the mass spectrometer was operated in positive mode with selected multiple reaction monitoring for JQ1 (<em>m</em>/<em>z</em> 457.0 → 401.0), OTX-015 (<em>m</em>/<em>z</em> 492.0 → 353.0), and SSB1 (<em>m</em>/<em>z</em> 780.0 → 617.0).</p></section><section id="sec17"><h3 class="pmc_sec_title">Anti-tumor ability</h3>
<p>Orthotopic MB NSG mice were randomly assigned to 7 groups (<em>n</em> = 5) and were administered the following treatments: PBS, JQ1-loaded nontargeted NPs, SSB1-loaded nontargeted NPs, JQ1 + SSB1-loaded nontargeted NPs, JQ1-loaded Try-derived NPs, SSB1-loaded Try-derived NPs, and JQ1 + SSB1-loaded Try-derived NPs. Each treatment was delivered via intravenous injection every 3 d at a dose of 20 mg/kg per compound. Body weight and MB tumor growth were monitored during the treatment. After the treatment period (total of 7 times of administration), mice were euthanized to dissect the brain and other major organs. Brain samples were fixed, sliced, and stained with hematoxylin and eosin (H&amp;E) and subjected to immunohistochemical staining for key proteins.</p></section><section id="sec18"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Statistical analysis was conducted by GraphPad Prism 8.0 (IBM Corp., Armonk, NY, USA). Data are displayed as mean ± standard deviation with replicates at least 3 times. Differences between 2 groups were analyzed using the <em>t</em> test, and those of more than 2 groups were analyzed using one-way analysis of variance using Tukey’s test. The data were considered significant when **<em>P</em> &lt; 0.01 and *<em>P</em> &lt; 0.05; ns means no significance.</p></section></section><section id="sec19"><h2 class="pmc_sec_title">Results</h2>
<section id="sec20"><h3 class="pmc_sec_title">SSB1 inhibits MB cell proliferation and GLI expression more efficiently than GDC-0449</h3>
<p>The viability of DAOY (SHH MB subtype) and D341 MED (group 3 MB subtype) cells after incubation with different concentrations of SSB1 was calculated using the MTT assay. SSB1 decreased the cell viability at a lower dose on both MB cell lines than that of GDC-0449 at various drug concentrations (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>A and B). The IC<sub>50</sub> of SSB1 was found to be significantly lower compared to those of GDC-0449 on DAOY cell lines (4.1 μM vs. 94.5 μM) and D341 MED cell lines (5.3 μM vs. 120.4 μM), indicating that SSB1 has a higher binding affinity to the SMO receptor compared to GDC-0449.</p>
<p>To determine whether SSB1 shows its effect by inhibiting SMO, we knocked down <em>SMO</em> expression by transfection of siSMO using Lipofectamine 2000 before treating cells with SSB1. <em>SMO</em> silencing in DAOY cells with siSMO was dose dependent, with almost 80% <em>SMO</em> silencing with 25 nM siSMO as determined by real-time PCR (Fig. <a href="#supplementary-material-1" class="usa-link">S3</a>). SMO knockdown in DAOY cells exhibited resistance to SSB1 treatment with a significant enhancement in IC<sub>50</sub> of 19.9 μM. In contrast, scrambled small-interfering-RNA-transfected cells showed no effect on the cell-killing potential of SSB1 (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>C). Moreover, JQ1-treated <em>SMO</em> knockdown MB cells have a similar IC<sub>50</sub> value as SMO-expressing MB cells (Fig. <a href="#supplementary-material-1" class="usa-link">S4</a>). These results indicate that JQ1 could overcome SMO mutation in MB treatment.</p></section><section id="sec21"><h3 class="pmc_sec_title">The combination of SMO and BRD4 inhibitors has a synergistic effect in MB killing and inhibiting colony formation</h3>
<p>To determine whether the combination of SMO and BRD4 inhibitors could improve MB treatment, we first determined the cell viability and colony formation ability of MB cells in the presence of SSB1 and JQ1. After 48-h incubation, JQ1 and SSB1 significantly decreased DAOY and D341 Med cell viability in a dose-dependent manner (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>D and E). The IC<sub>50</sub> of JQ1 were 4.2 μM in DAOY cells and 402 nM in D341 Med cells, whereas SSB1 has IC<sub>50</sub> values of 4.1 and 5.3 μM for DAOY and D341 Med cells, respectively. We further analyzed the synergistic effects of these 2 drugs by incubating DAOY and D341 Med cells with different drug ratios. JQ1 and SSB1 combination significantly decreased cell viability in of both these cell lines and showed a synergistic effect on cell killing, with the CI value lower than 1 at the ratios marked as a red cycle in these figures (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>F and G).</p>
<p>A colony formation assay was also carried out to determine whether SSB1 and JQ1 synergistically inhibited colony formation when DAOY and D341 MED cells were incubated with their combination. There was significant inhibition of colony formation after JQ1 or SSB1 incubation, and the inhibitory effect was the highest for the combination therapy in both these cell lines (Figs. <a href="#supplementary-material-1" class="usa-link">S2</a>H and I and <a href="#supplementary-material-1" class="usa-link">S5</a>).</p></section><section id="sec22"><h3 class="pmc_sec_title">JQ1 and SSB1 synergistically inhibit GLI expression, arrest the cell cycle, and promote the apoptosis of MB cells</h3>
<p>GLI proteins serve as crucial transcription factors within the Hh signaling pathway. Here, we confirmed SHH pathway inhibition by JQ1 and SSB1 by measuring the Hh pathway components at mRNA levels. As shown in Fig. <a href="#F1" class="usa-link">1</a>A and B, the combination of JQ1 and SSB1 significantly down-regulated key genes such as <em>GLI1</em>, <em>GLI2</em>, <em>SHH</em>, <em>PTCH1</em>, and <em>MYCN</em> compared to JQ1 or SSB1 treatment alone in both DAOY and D341 Med cells, indicating that JQ1 and SSB1 combination could synergistically inhibit <em>GLI</em> expression.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/22f20e13b6f9/bmr.0237.fig.001.jpg" loading="lazy" height="568" width="660" alt="Fig. 1."></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>JQ1 and saikosaponin B1 (SSB1) synergistically inhibit GLI expression, arrest cells in the G<sub>0</sub>/G<sub>1</sub> phase, and promote the apoptosis of medulloblastoma (MB) cells. (A and B) The inhibition of <em>GLI1/2</em>, <em>PTCH1</em>, <em>SHH</em>, and <em>MYCN</em> messenger RNA (mRNA) expression in DAOY and D341 Med cells with JQ1 and SSB1 treatment for 48 h was determined by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). (C and D) Cell cycle of DAOY and D341 Med cells treated with JQ1, SSB1, and their combination for 48 h. (E and F) Cell apoptosis of DAOY and D341 Med cells treated with JQ1, SSB1, and their combination for 48 h. (G and H) <em>CYCLIN D1</em> and <em>BAX</em> mRNA expression in DAOY and D341 Med cells after incubation with JQ1 and SSB1 combination (*<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01).</p></figcaption></figure><p>GLI is known to regulate the cell cycle by elevating cyclin D, a key factor essential for G<sub>1</sub> phase progression. After treatment with a JQ1 and SSB1 combination, the percentage of cells in the G<sub>1</sub> phase was significantly increased (70.9% ± 0.7% in DAOY and 73.7% ± 3.0% in D341 MED) compared to that in the control (40.6% ± 1.3% in DAOY and 35.1% ± 2.0% in D341 MED), and for monotherapy, it was 61.0% ± 2.4% for JQ1 and 54.8% ± 2.9% for SSB1 in DAOY cells, while it was 59.7% ± 1.9% for JQ1 and 51.3% ± 2.2% for SSB1 in D341 MED cells (Fig. <a href="#F1" class="usa-link">1</a>C and D and Fig. <a href="#supplementary-material-1" class="usa-link">S6</a>). Furthermore, apoptotic cells were quantified and analyzed by annexin V/PI double staining followed by flow cytometry (Fig. <a href="#F1" class="usa-link">1</a>E and F and Fig. <a href="#supplementary-material-1" class="usa-link">S7</a>). JQ1 and SSB1 could effectively induce apoptosis in DAOY cells (49.3% ± 1.5% and 47.0% ± 0.7%, respectively) compared to the control (2.3% ± 0.3%). In D341 MED cells, the apoptotic cells after treatment with JQ1 or SSB1 increased to 29.7% ± 0.3% and 27.4% ± 0.2%, respectively, compared to those in the control cells (15.9% ± 0.4%). The combination of these drugs further increased the apoptotic proportion (66.5% ± 0.8% for DAOY cells and 46.3% ± 1.0% for D341 MED cells), indicating that combination therapy could more effectively inhibit the tumor cell growth.</p>
<p>Next, cell-cycle- and apoptosis-related genes were investigated by measuring the associated molecules using the qRT-PCR assay. As shown in Fig. <a href="#F1" class="usa-link">1</a>G and H, there is an up-regulation in the mRNA levels of <em>CYCLIN D</em> and the pro-apoptotic gene <em>BAX</em>, which confirms that both JQ1 and SSB1 could inhibit MB cell proliferation by modulating the key regulators in the cell cycle and cell apoptosis.</p></section><section id="sec23"><h3 class="pmc_sec_title">The combination of SSB1 and JQ1 efficiently reduces MB stem cell proliferation</h3>
<p>It has been reported that SHH MB is driven by proliferative CD15<sup>+</sup> CSCs, which induce cell proliferation, therapy resistance, and metastasis. Here, we isolated CD15<sup>+</sup> CSCs from SHH MB cell lines DAOY and ONS-76 using a flow cytometer after incubating them with BV650-CD15 antibody. Both CD15<sup>+</sup> cells and CD15<sup>−</sup> cells were harvested, and CSC markers were determined using the qPCR assay. As shown in Fig. <a href="#F2" class="usa-link">2</a>A and B, the mRNA levels of stem cell markers such as <em>CD133</em>, <em>OCT4</em>, <em>SOX2</em>, and <em>MYC</em> were significantly higher in CD15<sup>+</sup> ONS-76 and DAOY cells compared to those in CD15<sup>−</sup> cells, indicating that CD15<sup>+</sup> ONS-76 and DAOY cells show a stem-like phenotype.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/a2caff800223/bmr.0237.fig.002.jpg" loading="lazy" height="550" width="660" alt="Fig. 2."></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>JQ1 and SSB1 synergistically down-regulate MB stem cell markers and reduce frequency. (A and B) mRNA levels of stem cell markers in CD15<sup>+</sup> MB and CD15<sup>−</sup> MB cells. (C and D) The mRNA levels of stem cell markers in CD15<sup>+</sup> DAOY and CD15<sup>+</sup> ONS-76 cells after incubation with JQ1 and SSB1 for 48 h were determined by real-time RT-PCR. (E and F) CD15<sup>+</sup> MB stem cell frequency reduced after incubation with JQ1, SSB1, and their combination. (G and H) CD133 expression on CD15<sup>+</sup> MB stem cells after incubation with JQ1, SSB1, and their combination (*<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01).</p></figcaption></figure><p>The stemness of CSCs is related to specific signaling pathway activation, including the SHH pathway. The activation of GLI could induce the expression of key genes such as <em>OCT4</em>, <em>SOX2</em>, and <em>NANOG</em> to maintain the stemness of CSCs. As JQ1 and SSB1 synergistically reduce <em>GLI</em> expression, we evaluated the treatment effects of these 2 drugs to inhibit CSCs’ proliferation and differentiation. After being treated with JQ1 and SSB1 for 48 h, the mRNA levels of stem cell markers such as <em>CD133</em>, <em>OCT4</em>, <em>SOX2</em>, <em>NANOG</em>, and <em>MYC</em> were significantly decreased compared to those of control and monotherapy (Fig. <a href="#F2" class="usa-link">2</a>C and D). Moreover, the CD15 and CD133 expression on the cell membrane surface was decreased after JQ1 and SSB1 co-incubation and was analyzed using a flow cytometry assay, which implies that the percentage of MB cells with a stem phenotype was reduced due to the treatment (Fig. <a href="#F2" class="usa-link">2</a>E to H). The key genes for CSCs to maintain stemness, such as <em>OCT4</em>, <em>SOX2</em>, and <em>NANOG</em>, were also significantly decreased after the combination treatment (Fig. <a href="#F2" class="usa-link">2</a>C and D), further implying that the stemness of CSCs was reduced and different from that of normal tumor cells.</p>
<p>We further investigated the cytotoxicity of JQ1 and SSB1 on MB stem cells. As shown in Fig. <a href="#F3" class="usa-link">3</a>A and B, both JQ1 and SSB1 show increased IC<sub>50</sub> values on CD15<sup>+</sup> DAOY (4.67 μM for JQ1 and 14.97 μM for SSB1) and CD15<sup>+</sup> ONS-76 stem cells (11.41 μM for JQ1 and 10.80 μM for SSB1) compared to normal DAOY cells (4.2 μM for JQ1 and 4.1 μM for SSB1) and ONS-76 cells (5.1 μM for JQ1 and 4.8 μM for SSB1, data not shown), indicating the drug resistance of stem cells. The combination of JQ1 and SSB1 could effectively and synergistically reduce the viability of MB stem cells compared to monotherapy. We further measured <em>LAMIN B1</em>, a senescent biomarker, and <em>CLEAVED CASPASE 3</em> expression in MB stem cells after treatment. The <em>LAMIN B1</em> mRNA expression in CD15<sup>+</sup> MB stem cells was significantly decreased after JQ1 treatment (Fig. <a href="#F3" class="usa-link">3</a>C and D), indicating a BET inhibitor (BETi) with the potential to lead to stem cell senescence. Next, the combination of JQ1 and SSB1 could also inhibit CD15<sup>+</sup> MB stem cell proliferation not only due to cell senescence but also by inducing cell apoptosis. As shown in Fig. <a href="#F3" class="usa-link">3</a>E and F, the combination of JQ1 and SSB1 synergistically increases the apoptosis of MB stem cells compared to JQ1 and SSB1 monotherapy, analyzed using flow cytometry (CI value &lt;0.8).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/2dbdb31f5cf1/bmr.0237.fig.003.jpg" loading="lazy" height="455" width="659" alt="Fig. 3."></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>JQ1 and SSB1 synergistically increase MB stem cell apoptosis. (A and B) JQ1 and SSB1 inhibit CD15<sup>+</sup> MB stem cell viability in a dose-dependent manner. (C and D) mRNA expression of senescent markers in CD15<sup>+</sup> MB stem cells with JQ1 and SSB1 incubation for 48 h. (E and F) The apoptosis of CD15<sup>+</sup> MB stem cells after incubation with JQ1, SSB1, and their combination, as well as the representative flow cytometry scatter plots. PI, propidium iodide; FITC, fluorescein isothiocyanate.</p></figcaption></figure></section><section id="sec24"><h3 class="pmc_sec_title">SSB1 and JQ1 synergistically inhibit MB metastasis</h3>
<p>The metastasis of cancer is a complex multistep process, including migrating and invading tumor cells, which involves multiple genetic alterations. MMP-mediated degradation of the ECM represents a critical step in the metastatic process. MMPs produced by tumor cells could destroy the matrix barriers surrounding the tumor, helping tumor cells migrate and invade the surrounding connective tissues, blood vessels, or cerebrospinal fluid for the MB to metastasize to distant organs. Previous research has shown that MMPs exhibit elevated expression across a broad spectrum of tumors, including MB. MMP2 is one of the key promoters related to the migration and invasion of MB. We first measured <em>MMP2</em> levels in normal brain cells and MB cells. The mRNA level of <em>MMP2</em> was elevated in MB cell lines in SHH MB and group 3 MB compared to that in normal brain cell lines (Fig. <a href="#supplementary-material-1" class="usa-link">S8</a>), consistent with previous research. MMP2 was directly regulated by BRD4 and PI3K/AKT signaling. JQ1 could directly reduce BRD4 transcription, and SSB1 could inhibit <em>GLI2</em> expression, another critical transcription factor of MMP2. Therefore, we speculated that JQ1 and SSB1 could synergistically reduce MMP2 expression and further reduce the migration and invasion of MB cells. As shown in Fig. <a href="#F4" class="usa-link">4</a>A and B, the mRNA level of MMP2 was significantly reduced after JQ1 and SSB1 combination treatment.</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/3cf65465a3e6/bmr.0237.fig.004.jpg" loading="lazy" height="599" width="660" alt="Fig. 4."></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>JQ1 and SSB1 synergistically down-regulate MMP2 and inhibit MB metastasis. (A and B) JQ1 and SSB1 down-regulate <em>MMP2</em> mRNA expression in MB cells. (C and D) The microscope images and quantitative analysis of DAOY and D341 Med cells after incubation with JQ1, SSB1, and their combination. The microscope images and quantitative analysis of MB cell migration (E and F) and invasion (G and H) after incubation with JQ1, SSB1, and their combination (*<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01). GSH, glutathione; DAPI, 4′,6-diamidino-2-phenylindole; OCT2, organic cation transporter 2.</p></figcaption></figure><p>Next, we investigated the migration and invasion ability of MB cells after JQ1 and SSB1 combination treatment. The wound healing assay was a primary method for cell migration investigation. After creating a scratch on the MB cell monolayer, cells were incubated with JQ1, SSB1, and their combination for 24 h. The scratch wound was almost healed in the control group, with full cells migrating into the wound area, while the wound space remained after incubation with JQ1 and SSB1 alone (Fig. <a href="#F4" class="usa-link">4</a>C and D). The combination exhibits limited cell migration into the wound area, which most effectively reduces cell migration in both SHH MB and group 3 MB. Further, the transwell cell migration assay was also used to confirm the migration ability of MB cells. As shown in Fig. <a href="#F4" class="usa-link">4</a>E and F, the combination treatment most effectively reduced MB cell migration in both subtypes of MB compared to control and monotherapy. The cell invasion across Matrigel was further investigated. Data suggested that the combination of JQ1 and SSB1 could also inhibit both DAOY and D341 Med cell invasion, indicating the possibility of the combination inhibiting MB metastasis (Fig. <a href="#F4" class="usa-link">4</a>G and H).</p></section><section id="sec25"><h3 class="pmc_sec_title">Formulation and characterization of drug-loaded Try-derived NPs</h3>
<p>Try-Lips were synthesized following the route in Fig. <a href="#supplementary-material-1" class="usa-link">S8</a>. The structure of Try-Lips was confirmed by the <sup>1</sup>H nuclear magnetic resonance spectrum (Fig. <a href="#supplementary-material-1" class="usa-link">S9</a>). JQ1- and SSB1-loaded Try-derived NPs were formulated by film hydration assay. The particle sizes of drug-loaded nontargeted NPs and Try-derived NPs were 69.19 ± 1.46 and 79.22 ± 1.83 nm (Fig. <a href="#F5" class="usa-link">5</a>A), respectively, which are suitable for both BBB penetration and avoids kidney excretion to increase the long circulation in vivo. The transmission electron microscopy images confirmed the spherical shape of nontargeted NPs and Try-derived NPs with a consistent particle size (Fig. <a href="#F5" class="usa-link">5</a>B). This particle size range is suitable for both BBB penetration and avoids kidney excretion to increase the long circulation in vivo. The DL capacity and encapsulation efficiency of JQ1 were 9.3% ± 0.3% and 90.3% ± 2.8%, respectively, whereas those of SSB1 were 5.1% ± 0.1% and 87.7% ± 1.1%, respectively, indicative of the acceptable DL of JQ1 and SSB1 in Try-derived NPs.</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/0e39fee5fa38/bmr.0237.fig.005.jpg" loading="lazy" height="660" width="655" alt="Fig. 5."></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Characterization of drug-loaded nanoparticles (NPs). (A) Dynamic light scattering (DLS) of JQ1- and SSB1-loaded nontargeted NPs and tryptamine (Try)-derived NPs. (B) NP morphology analyzed by transmission electron microscopy (TEM). (C) The cumulative release profiles of JQ1 and SSB1 in nontargeted NPs and Try-derived NPs at pH 7.4 and 6.8. (D) Stability of JQ1- and SSB1-loaded nano-targeted NPs and Try-derived NPs at room temperature for 72 h. (E and F) Cell viability of MB cells after 48-h incubation with JQ1- and SSB1-loaded nontargeted NPs and Try-derived NPs. (G) Scheme of the in vitro transwell blood–brain barrier (BBB) model. (H and I) The cellular uptake of Cy5.5-decorated nontargeted NPs and Try-derived NPs in human brain microvascular endothelial cells (HBMECs) and MB cells after 4-h incubation was analyzed using flow cytometry. (J) The cellular uptake of Cy5.5-decorated nontargeted NPs and Try-derived NPs in DAOY cells was observed by confocal microscopy.</p></figcaption></figure><p>Release curves are indicative of the little effects of Try decoration on drug release compared to those of nontargeted NPs in 48 h at pH 7.4 (Fig. <a href="#F5" class="usa-link">5</a>C). The cumulative release was not significantly improved in the weak acid environment at pH 6.8 either, whereas the drug was rapidly released to the medium from Try-derived NPs in the presence of glutathione (GSH) at pH 6.8 compared to that under conditions without GSH, suggesting that the drug-loaded Try-derived NPs exhibited a reductive responsive drug release, which could target released anti-tumor agents only in tumor cells with extremely high intracellular GSH levels (Fig. <a href="#F5" class="usa-link">5</a>C). In the stability investigation, the particle sizes of drug-loaded formulations remained stable within 72 h of storage at 4 °C (Fig. <a href="#F5" class="usa-link">5</a>D), suggesting the acceptable stability of Try-derived NPs. The cytotoxicity of drug-loaded Try-derived NPs was evaluated in both SHH MB and group 3 MB cells. Try-derived NPs significantly reduced cell viability compared to nontargeted NPs in all MB cell lines at the same dosage, indicating the higher uptake of drug-loaded Try-derived NPs by MB cells compared to nontargeted NPs (Fig. <a href="#F5" class="usa-link">5</a>E and F and Fig. <a href="#supplementary-material-1" class="usa-link">S10</a>).</p></section><section id="sec26"><h3 class="pmc_sec_title">Try-derived NPs show BBB permeability and increase drug accumulation in the brain</h3>
<p>To assess BBB permeability, we established an in vitro BBB model using the transwell assay (Fig. <a href="#F5" class="usa-link">5</a>G and Fig. <a href="#supplementary-material-1" class="usa-link">S11</a>). The cellular uptake of Cy5.5-decorated DSPE-PEG<sub>2k</sub> was incorporated into the preparation of Try-derived NPs and nontargeted NPs for the cellular uptake investigation. After adding them to the upper chamber, they were incubated with HBMECs for 6 h. Cy5.5-labeled Try-derived NPs exhibited the highest fluorescence intensity in HBMECs, suggesting excellent cellular uptake by BBB endothelial cells (Fig. <a href="#F5" class="usa-link">5</a>H). Similar data were observed in 3 types of MB cell lines that adhered in the lower chamber, indicating that the Cy5.5-decorated Try-derived NPs improved BBB crossing compared to nontargeted NPs (Fig. <a href="#F5" class="usa-link">5</a>I). We further used confocal microscopy to confirm the cellular uptake of NPs in DAOY cells. As shown in Fig. <a href="#F5" class="usa-link">5</a>J, the intracellular Cy5.5 signals were significantly brighter than those of the free group and nontargeted NPs, confirming the stronger cellular uptake of Try-derived NPs in MB cells. Moreover, we further located the OCT2 expression on MB cells and observed the signal overlaps of OCT2 and Try-derived NPs, which led us to speculate that the Try-derived NPs were taken up into MB cells through OCT2-mediated assay.</p>
<p>We further investigated the BBB crossing ability of Try-derived NPs in vivo in both healthy NSG mice and orthotopic MB-bearing mice. In healthy mice, the Try-derived NP group exhibited higher Cy5.5 signals in the brain than the nontargeted NP group 2 h post-administration, which was observed using IVIS (Fig. <a href="#F6" class="usa-link">6</a>A). The accumulation of NPs in the brain was further confirmed using a confocal microscope by analyzing the mouse brain sections. Stronger Cy5.5 signals were observed in the brain section of healthy mice injected with Try-derived NPs than in those injected with nontargeted NPs, also indicative of Try decoration improving the BBB permeability of NPs (Fig. <a href="#F6" class="usa-link">6</a>B).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/50258196610c/bmr.0237.fig.006.jpg" loading="lazy" height="660" width="416" alt="Fig. 6."></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Try-derived NPs significantly enhance BBB permeability and drug biodistribution after systemic administration. (A and B) Try-derived NPs conjugated with Cy5.5 significantly increase brain permeability compared to nontargeted NPs in healthy NSG mice analyzed using the IVIS system and confocal microscopy. (C) Try-decorated NPs conjugated with Cy5.5 significantly increase MB tumor cellular uptake compared to nontargeted NPs in MB-bearing NSG mice. (D) JQ1 and SSB1 concentrations in the brains of orthotopic MB tumor-bearing NSG mice at 6 and 24 h post-systemic administration of drug-loaded Try-derived NPs or nontargeted NPs at a dose of 10 mg/kg (*<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01). GFP, green fluorescent protein.</p></figcaption></figure><p>Moreover, we evaluated the MB-targeting ability of Try-derived NPs in orthotopic MB tumor-bearing NSG mice. Mouse brains were also extracted to prepare frozen slides for observation using a confocal microscope. A similar phenomenon was observed in orthotopic MB tumor-bearing mice. Cy5.5 signals were located and overlapped with green fluorescent protein green signals, which belong to the MB cells in mouse brain sections, after injecting Try-derived NPs, but were hardly observed in nontargeted NP groups, which confirmed the ability of Try-derived NPs in targeting MB in vivo (Fig. <a href="#F6" class="usa-link">6</a>C).</p>
<p>The biodistribution of JQ1 and SSB1 in orthotopic MB-bearing mice was measured using LC–MS. Try-derived NPs could efficiently cross the BBB and significantly increase JQ1 and SSB1 accumulation in the cerebellum 6 h (0.28 ± 0.10 ng/mg for JQ1 and 0.73 ± 0.32 ng/mg for SSB1) and 24 h (0.036 ± 0.019 ng/mg for JQ1 and 0.109 ± 0.032 ng/mg for SSB1) after injection compared to nontargeted NPs (0.032 ± 0.015 ng/mg for JQ1 and 0.137 ± 0.057 ng/mg for SSB1 at 6 h and 0.003 ± 0.002 ng/mg for JQ1 and 0.039 ± 0.018 ng/mg for SSB1 at 24 h) (Fig. <a href="#F6" class="usa-link">6</a>D), confirming that Try-derived NPs prolonged drug accumulation in MB.</p></section><section id="sec27"><h3 class="pmc_sec_title">JQ1 and SSB1 combination exerts superior anti-MB efficacy in the orthotopic MB mouse model via Try-derived NP delivery</h3>
<p>The therapeutic efficiency of the JQ1 and SSB1 combination on SHH MB was investigated in the tumor-bearing NSG mouse model. The bioluminescence signals of the MB tumor were significantly reduced in mice injected with a combination loaded into Try-derived NPs compared to those in mice injected with nontargeted NPs (Fig. <a href="#F7" class="usa-link">7</a>A and B). Consistent with previous data, Try-derived NPs exhibited superior therapeutic efficiency due to strong BBB permeability and MB-targeting ability compared to nontargeted NPs. The body weight of mice injected with Try-derived NPs showed no significant decrease (Fig. <a href="#F7" class="usa-link">7</a>C), indicating that Try-derived NPs are ideal delivery systems with low systemic toxicity. Brain tissue sections from each treatment group were subjected to H&amp;E staining and immunohistochemical analysis (Fig. <a href="#F7" class="usa-link">7</a>D). The H&amp;E staining confirmed that the MB area was significantly reduced after JQ1 and SSB1 treatment. Reduced proliferation marker Ki67 staining and observed apoptotic marker cleaved caspase-3 also confirm that the combination could effectively inhibit MB progression. Moreover, the MMP2 staining was also reduced after treatment, indicating the potential of the combination of the BRD4 inhibitor and SMO inhibitor in preventing MB metastasis. The expression of stem-related regulator OCT4 was also reduced after treatment, suggesting that the combination could further inhibit the activation of MB stem cells.</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/12332260/64d400f4221c/bmr.0237.fig.007.jpg" loading="lazy" height="660" width="656" alt="Fig. 7."></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Anti-tumor efficacy of targeted NPs loaded with JQ1 and SSB1 after systemic administration into orthotopic MB-bearing NSG mice. (A) Bioluminescence images and (B) quantitative analysis of IVIS signal intensity (photons/s/cm<sup>2</sup>/sr) of MB tumors at different times. (C) Average mouse body weight changes during treatment. (D) Representative microscopic pictures of hematoxylin and eosin (H&amp;E) and immunohistochemical staining of MB tissues for OCT4, MMP2, KI67, and CLEAVED CASPASE 3. Scale bar 100 μm, inset image ×20.</p></figcaption></figure></section></section><section id="sec28"><h2 class="pmc_sec_title">Discussion</h2>
<p>MB ranks among the most prevalent malignant central nervous system tumors, generated in the pediatric cerebellum. The therapeutic strategy of MB, including surgery, radiation, and chemotherapy, could limitedly improve the survival of patients but often at the expense of lifelong side effects such as endocrine dysfunction, ataxia, and emotional lability. Furthermore, MB exhibits a high chance of spinal metastases and also the highest probability of extraneural dissemination of all central nervous system tumors. Therefore, developing a targeting therapy strategy based on disentangling the molecular basis of MB is urgently needed. SHH MB and group 3 MB were the most malignant, with poor prognosis. IGF-II activation triggers PI3K signaling, thereby collaborating with SHH/GLI to promote the progression of SHH MB progression. Group 3 MB is mostly induced by <em>MYC</em> overexpression, which will also affect GLI, a crucial transcription factor within the SHH signaling cascade. Our previous data confirmed the overexpression of GLI, MYC, and p-PI3K/p-AKT in MB patient samples. Therefore, the SHH and MYC pathways’ co-inhibition might be more effective than monotherapy.</p>
<p>SSB1, a potent SMO inhibitor, was extracted and purified from the roots of the traditional medicinal herb Chinese Thorowax. SSB1, as an SMO inhibitor, binds with SMO proteins, which inhibits its activation and expression of downstream GLI and SUFU. Our evaluation confirmed the better therapeutic efficacy of SSB1 in vitro compared to that of the commercial SMO inhibitor vismodegib (GDC-0449), with a lower IC<sub>50</sub> value. Previous research implies that JQ1 could inhibit both MYC- and GLI-amplified tumors by binding to the BRD4 protein and reducing <em>MYC</em> and <em>GLI</em> transcription. As a transcriptional regulator, BRD4 exerts a pivotal function in embryogenesis and tumorigenesis. During the transcription process, the mediator protein complex is recruited by BRD4 and forms super-enhancer complexes to promote RNA polymerase II activity, stimulating transcription initiation and elongation. In contrast, JQ1 could directly bind with the BRD4 protein by occluding the acetyl-lysine binding pocket unique to BET family proteins. Competitively binding with JQ1, BRD4 is displaced from chromatin and inhibit super-enhancer complex formation, which reduces the <em>MYC</em> and <em>GLI</em> oncogenes’ transcription. Therefore, SSB1 combined with JQ1 was selected to improve SHH MB and group 3 MB treatment efficiency. The MTT and colony formation assays confirmed that the JQ1 and SSB1 combination could synergistically increase cell killing compared to monotherapy. The expression of key regulators such as <em>GLI</em>, <em>MYCN</em>, <em>SHH</em>, and <em>PTCH1</em> significantly decreased after incubating with the JQ1 and SSB1 combination, indicating that the combination could synergistically regulate the SHH pathway and increase apoptosis. The therapeutic resistance of SMO inhibitors to SHH MB was observed in several clinical trials. The SMO protein loses the ability to bind to the SMO inhibitor due to the mutation. Based on our research data, JQ1, as a BETi, could also regulate the SHH pathway by directly reducing the downstream genes of SMO, which could overcome the resistance of SMO inhibitors.</p>
<p>CSC populations in the brain, also termed brain tumor-initiating cells (BTICs), have been detected in different subtypes of MB based on cell surface markers. Read et al. [<a href="#B45" class="usa-link" aria-describedby="B45">45</a>] and Ward et al. [<a href="#B46" class="usa-link" aria-describedby="B46">46</a>] all confirmed that CD15 could be a primitive stem-like cell marker of BTIC populations in the SHH MB mouse model. Therefore, the effects of JQ1 and SSB1 on CSCs were investigated using CD15<sup>+</sup> SHH MB stem cells sorted from DAOY and ONS-76 cell lines. The transcription factors GLI1/2, as the SHH signaling pathway’s prominent effectors, could also regulate key factors such as OCT4, SOX2, NANOG, and MYCN in self-renewal and keep the stemness of CSCs. OCT4 and SOX2 have been reported to maintain CSC survival by inhibiting apoptosis and promoting cell proliferation by activating the OCT4/TCL1/AKT pathway and SOX2/ORAIL/STIM1 pathway, respectively. NANOG could directly target LIF/STAT3 to maintain CSCs in an undifferentiated state and maintain the self-renewal of CSCs through the IGF1R signaling pathway. The expression of these key stem cell markers was regulated by feedback loops between these genes and regulated by transcription factors such as GLI and MYC or epigenetic readers like BRD4. JQ1 and SSB1 could synergistically inhibit <em>GLI</em> and <em>MYCN</em> expression and follow regulated stem cell markers. JQ1 could also reduce pluripotent gene transcription by directly inhibiting BRD4. Therefore, the combination of a BETi (JQ1) and an SMO inhibitor (SSB1) exhibited potential for synergistic blocking of SHH and MYC pathways, which play key roles in regulating the self-renewal and maintenance of MB stem cells, to reduce stem cell proliferation and maintenance and overcome the drawbacks of monotherapy.</p>
<p>The intraspinal metastasis of MB occurs via the cerebrospinal fluid pathway, which is the initial step in ECM degradation. MMPs have been suggested as the key endopeptidases working on degrading ECM components, reducing MB adhesive connections, and enhancing MB metastasis. Within the MMP family, MMP2, as a gelatinase, plays a pivotal role in tumor invasion, and several groups confirm MMP2’s high expression in MB patient tissues. MMP2 secreted and activated by MB cells can degrade collagen IV surrounding tumors and the basement membrane, resulting in the invasion of MB cells into nearby tissues, followed by tumor growth and spread through capillary endothelium and neovascularization. Therefore, inhibiting MMP2 expression and activation could effectively reduce the metastasis of MB. The <em>MMP2</em> gene could be directly regulated by BRD4. JQ1 as a BETi could competitively inhibit BRD4 binding on the promoter, reducing <em>MMP2</em> mRNA transcription and inhibiting MMP2 expression. Further, the metastasis of MB could also be regulated by GLI1, a key transcription factor in the SHH pathway. The polycomb protein BMI1 is a key regulator of neural stem cells, and BTIC is implicated in the pathogenesis, progression, and metastasis of MB. Previous studies suggested that GLI1 may activate the promoter of <em>BMI1</em> and enhance its protein expression [<a href="#B18" class="usa-link" aria-describedby="B18">18</a>]. JQ1 and SSB1 both could reduce <em>GLI</em> expression, followed by down-regulation of downstream genes <em>TWIST1</em> and <em>BMI1</em>, indicating the synergistic effects on inhibiting MB metastasis.</p>
<p>Due to the existence of the BBB, passive targeting of NPs is nearly ineffective in transporting them into the brain and uptake by MB cells. To improve the biodistribution of drugs in MB, we used Try-decorated lipid NPs to achieve BBB penetration and MB targeting accumulation. Try-derived NPs could increase cellular uptake based on OCT2 medium cell transport, effectively crossing the BBB and improving their biodistribution. Compared to passive targeting groups, Try-derived NPs significantly increase the drug accumulation of NPs in MB tumor areas with extraordinary treatment efficiency.</p>
<p>Overall, JQ1 and SSB1 combinations exhibit the potential to synergistically inhibit MB progression and metastasis by increasing the cell cycle arrest and apoptosis of MB cells and reducing the frequency of the MB stem cell population. Try-derived NPs, as a promising BBB penetration delivery system, could effectively enhance the intracranial delivery of JQ1 and SSB1 combination and eliminate MB tumors with no observed toxicity.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p><strong>Funding:</strong> This work was supported by the National Natural Science Foundation of China (Grant Nos. 32301178 and 32371444), the Natural Science Foundation of Jiangsu Province (Grant No. BK20230316), the Natural Science Foundation of Jiangsu Province-Outstanding Youth Foundation (Grant No. BK20220102), and the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 23KJB350003). This work was also supported by the Discipline Fund of the School of Pharmacy from Nanjing Tech University (Grant No. 202303) and NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients and Department of Pharmaceutics (Grant No. PPE2023002).</p>
<p><strong>Author contributions:</strong> Q.W.: Writing—original draft, supervision, project administration, methodology, funding acquisition, and conceptualization. H.R.: Supervision, funding acquisition, and conceptualization. Z.M.: Supervision and conceptualization. Z.C.: Formal analysis and data curation. C.G.: Methodology, investigation, and formal analysis. J.C.: Methodology and investigation. R.Z.: Software, resources, and methodology. Y.Z.: Writing—revised draft. X.L.: Writing—revised draft.</p>
<p><strong>Competing interests:</strong> The authors declare that they have no competing interests.</p></section><section id="sec29"><h2 class="pmc_sec_title">Data Availability</h2>
<p>Data will be made available on request.</p></section><section id="supplementary-material-1"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="supp-1"><div class="caption p">
<span>Supplementary 1</span><p>Figs. S1 to S11</p>
<p>Table S1</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12332260/bin/bmr.0237.f1.docx" data-ga-action="click_feat_suppl" class="usa-link">bmr.0237.f1.docx</a><sup> (2.4MB, docx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA. 
Medulloblastomics revisited: Biological and clinical insights from thousands of patients. Nat Rev Cancer. 2020;20(1):42–56.
</cite> [<a href="https://doi.org/10.1038/s41568-019-0223-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9113832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31819232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Medulloblastomics%20revisited:%20Biological%20and%20clinical%20insights%20from%20thousands%20of%20patients&amp;volume=20&amp;issue=1&amp;publication_year=2020&amp;pages=42-56&amp;pmid=31819232&amp;doi=10.1038/s41568-019-0223-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, et al. 
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813–820.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(06)70867-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17012043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Risk-adapted%20craniospinal%20radiotherapy%20followed%20by%20high-dose%20chemotherapy%20and%20stem-cell%20rescue%20in%20children%20with%20newly%20diagnosed%20medulloblastoma%20(St%20Jude%20Medulloblastoma-96):%20Long-term%20results%20from%20a%20prospective,%20multicentre%20trial&amp;volume=7&amp;issue=10&amp;publication_year=2006&amp;pages=813-820&amp;pmid=17012043&amp;doi=10.1016/S1470-2045(06)70867-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, et al. 
Relapse patterns and outcome after relapse in standard risk medulloblastoma: A report from the HIT-SIOP-PNET4 study. J Neuro-Oncol. 2016;129(3):515–524.</cite> [<a href="https://doi.org/10.1007/s11060-016-2202-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5020107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27423645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuro-Oncol&amp;title=Relapse%20patterns%20and%20outcome%20after%20relapse%20in%20standard%20risk%20medulloblastoma:%20A%20report%20from%20the%20HIT-SIOP-PNET4%20study&amp;volume=129&amp;issue=3&amp;publication_year=2016&amp;pages=515-524&amp;pmid=27423645&amp;doi=10.1007/s11060-016-2202-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Miranda Kuzan-Fischer C, Juraschka K, Taylor MD. 
Medulloblastoma in the molecular era. J Korean Neurosurg Soc. 2018;61(3):292–301.
</cite> [<a href="https://doi.org/10.3340/jkns.2018.0028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5957312/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29742881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Korean%20Neurosurg%20Soc&amp;title=Medulloblastoma%20in%20the%20molecular%20era&amp;volume=61&amp;issue=3&amp;publication_year=2018&amp;pages=292-301&amp;pmid=29742881&amp;doi=10.3340/jkns.2018.0028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Salloum R, Chen Y, Yasui Y, Packer R, Leisenring W, Wells E, King A, Howell R, Gibson TM, Krull KR, et al. 
Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2019;37(9):731–740.
</cite> [<a href="https://doi.org/10.1200/JCO.18.00969" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6424138/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30730781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Late%20morbidity%20and%20mortality%20among%20medulloblastoma%20survivors%20diagnosed%20across%20three%20decades:%20A%20report%20from%20the%20Childhood%20Cancer%20Survivor%20Study&amp;volume=37&amp;issue=9&amp;publication_year=2019&amp;pages=731-740&amp;pmid=30730781&amp;doi=10.1200/JCO.18.00969&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, et al. 
Molecular subgroups of medulloblastoma: The current consensus. Acta Neuropathol. 2012;123(4):465–472.
</cite> [<a href="https://doi.org/10.1007/s00401-011-0922-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3306779/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22134537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=Molecular%20subgroups%20of%20medulloblastoma:%20The%20current%20consensus&amp;volume=123&amp;issue=4&amp;publication_year=2012&amp;pages=465-472&amp;pmid=22134537&amp;doi=10.1007/s00401-011-0922-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DT, Pajtler KW, et al. 
Spectrum and prevalence of genetic predisposition in medulloblastoma: A retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018;19(6):785–798.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(18)30242-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5984248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29753700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Spectrum%20and%20prevalence%20of%20genetic%20predisposition%20in%20medulloblastoma:%20A%20retrospective%20genetic%20study%20and%20prospective%20validation%20in%20a%20clinical%20trial%20cohort&amp;volume=19&amp;issue=6&amp;publication_year=2018&amp;pages=785-798&amp;pmid=29753700&amp;doi=10.1016/S1470-2045(18)30242-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Northcott PA, Dubuc AM, Pfister S, Taylor MD. 
Molecular subgroups of medulloblastoma. Expert Rev Neurother. 2012;12(7):871–884.
</cite> [<a href="https://doi.org/10.1586/ern.12.66" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4334443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22853794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev%20Neurother&amp;title=Molecular%20subgroups%20of%20medulloblastoma&amp;volume=12&amp;issue=7&amp;publication_year=2012&amp;pages=871-884&amp;pmid=22853794&amp;doi=10.1586/ern.12.66&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Yang Z, Liu X, Xu H, Teschendorff AE, Xu L, Li J, Fu M, Liu J, Zhou H, Wang Y, et al. 
Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma. Commun Biol. 2024;7(1):
Article 824.
</cite> [<a href="https://doi.org/10.1038/s42003-024-06488-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11227553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38971948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun%20Biol&amp;title=Integrative%20analysis%20of%20genomic%20and%20epigenomic%20regulation%20reveals%20miRNA%20mediated%20tumor%20heterogeneity%20and%20immune%20evasion%20in%20lower%20grade%20glioma&amp;volume=7&amp;issue=1&amp;publication_year=2024&amp;pages=Article%20824&amp;pmid=38971948&amp;doi=10.1038/s42003-024-06488-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, et al. 
Astrocytic <em>trans</em>-differentiation completes a multicellular paracrine feedback loop required for medulloblastoma tumor growth. Cell. 2020;180(3):502–520.e19.
</cite> [<a href="https://doi.org/10.1016/j.cell.2019.12.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7259679/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31983537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Astrocytic%20trans-differentiation%20completes%20a%20multicellular%20paracrine%20feedback%20loop%20required%20for%20medulloblastoma%20tumor%20growth&amp;volume=180&amp;issue=3&amp;publication_year=2020&amp;pages=502-520.e19&amp;pmid=31983537&amp;doi=10.1016/j.cell.2019.12.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Huang M, Tailor J, Zhen Q, Gillmor AH, Miller ML, Weishaupt H, Chen J, Zheng T, Nash EK, McHenry L, et al. 
Engineering genetic predisposition in human neuroepithelial stem cells recapitulates medulloblastoma tumorigenesis. Cell Stem Cell. 2019;25(3):433–446.e7.
</cite> [<a href="https://doi.org/10.1016/j.stem.2019.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6731167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31204176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Stem%20Cell&amp;title=Engineering%20genetic%20predisposition%20in%20human%20neuroepithelial%20stem%20cells%20recapitulates%20medulloblastoma%20tumorigenesis&amp;volume=25&amp;issue=3&amp;publication_year=2019&amp;pages=433-446.e7&amp;pmid=31204176&amp;doi=10.1016/j.stem.2019.05.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Huang GH, Xu QF, Cui YH, Li N, Bian XW, Lv SQ. 
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy. Cancer Sci. 2016;107(5):583–589.
</cite> [<a href="https://doi.org/10.1111/cas.12925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4970825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27171351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci&amp;title=Medulloblastoma%20stem%20cells:%20Promising%20targets%20in%20medulloblastoma%20therapy&amp;volume=107&amp;issue=5&amp;publication_year=2016&amp;pages=583-589&amp;pmid=27171351&amp;doi=10.1111/cas.12925&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Manoranjan B, Venugopal C, McFarlane N, Doble BW, Dunn SE, Scheinemann K, Singh SK. 
Medulloblastoma stem cells: Modeling tumor heterogeneity. Cancer Lett. 2013;338(1):23–31.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2012.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22796365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=Medulloblastoma%20stem%20cells:%20Modeling%20tumor%20heterogeneity&amp;volume=338&amp;issue=1&amp;publication_year=2013&amp;pages=23-31&amp;pmid=22796365&amp;doi=10.1016/j.canlet.2012.07.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Manoranjan B, Venugopal C, McFarlane N, Doble BW, Dunn SE, Scheinemann K, Singh SK. 
Medulloblastoma stem cells: Where development and cancer cross pathways. Pediatr Res. 2012;71(2):516–522.
</cite> [<a href="https://doi.org/10.1038/pr.2011.62" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22430388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Res&amp;title=Medulloblastoma%20stem%20cells:%20Where%20development%20and%20cancer%20cross%20pathways&amp;volume=71&amp;issue=2&amp;publication_year=2012&amp;pages=516-522&amp;pmid=22430388&amp;doi=10.1038/pr.2011.62&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Fan X, Eberhart CG. 
Medulloblastoma stem cells. J Clin Oncol. 2008;26(17):2821–2827.
</cite> [<a href="https://doi.org/10.1200/JCO.2007.15.2264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4508659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18539960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Medulloblastoma%20stem%20cells&amp;volume=26&amp;issue=17&amp;publication_year=2008&amp;pages=2821-2827&amp;pmid=18539960&amp;doi=10.1200/JCO.2007.15.2264&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, et al. 
Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):
Article 8.</cite> [<a href="https://doi.org/10.1038/s41392-020-0110-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7005297/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32296030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct%20Target%20Ther&amp;title=Targeting%20cancer%20stem%20cell%20pathways%20for%20cancer%20therapy&amp;volume=5&amp;issue=1&amp;publication_year=2020&amp;pages=Article%208&amp;pmid=32296030&amp;doi=10.1038/s41392-020-0110-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, et al. 
Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nat Commun. 2018;9(1):
Article 4121.
</cite> [<a href="https://doi.org/10.1038/s41467-018-06564-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6175869/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30297829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Notch1%20regulates%20the%20initiation%20of%20metastasis%20and%20self-renewal%20of%20Group%203%20medulloblastoma&amp;volume=9&amp;issue=1&amp;publication_year=2018&amp;pages=Article%204121&amp;pmid=30297829&amp;doi=10.1038/s41467-018-06564-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Wang X, Venugopal C, Manoranjan B, McFarlane N, O’Farrell E, Nolte S, Gunnarsson T, Hollenberg R, Kwiecien J, Northcott P, et al. 
Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. Oncogene. 2012;31(2):187–199.
</cite> [<a href="https://doi.org/10.1038/onc.2011.232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21685941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Sonic%20hedgehog%20regulates%20Bmi1%20in%20human%20medulloblastoma%20brain%20tumor-initiating%20cells&amp;volume=31&amp;issue=2&amp;publication_year=2012&amp;pages=187-199&amp;pmid=21685941&amp;doi=10.1038/onc.2011.232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Lytle NK, Barber AG, Reya T. 
Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018;18(11):669–680.
</cite> [<a href="https://doi.org/10.1038/s41568-018-0056-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8388042/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30228301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Stem%20cell%20fate%20in%20cancer%20growth,%20progression%20and%20therapy%20resistance&amp;volume=18&amp;issue=11&amp;publication_year=2018&amp;pages=669-680&amp;pmid=30228301&amp;doi=10.1038/s41568-018-0056-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Martin A, Cano A. 
Tumorigenesis: Twist1 links EMT to self-renewal. Nat Cell Biol. 2010;12(10):924–925.
</cite> [<a href="https://doi.org/10.1038/ncb1010-924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20885418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Cell%20Biol&amp;title=Tumorigenesis:%20Twist1%20links%20EMT%20to%20self-renewal&amp;volume=12&amp;issue=10&amp;publication_year=2010&amp;pages=924-925&amp;pmid=20885418&amp;doi=10.1038/ncb1010-924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Vince GH, Herbold C, Klein R, Kühl J, Pietsch T, Franz S, Roosen K, Tonn JC. 
Medulloblastoma displays distinct regional matrix metalloprotease expression. J Neuro-Oncol. 2001;53(2):99–106.</cite> [<a href="https://doi.org/10.1023/a:1012241031138" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11716074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuro-Oncol&amp;title=Medulloblastoma%20displays%20distinct%20regional%20matrix%20metalloprotease%20expression&amp;volume=53&amp;issue=2&amp;publication_year=2001&amp;pages=99-106&amp;pmid=11716074&amp;doi=10.1023/a:1012241031138&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, Ramírez-Camacho MA, Alvarez-Sánchez ME. 
Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. 2019;9:
Article 1370.
</cite> [<a href="https://doi.org/10.3389/fonc.2019.01370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6915110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31921634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Role%20of%20matrix%20metalloproteinases%20in%20angiogenesis%20and%20cancer&amp;volume=9&amp;publication_year=2019&amp;pages=Article%201370&amp;pmid=31921634&amp;doi=10.3389/fonc.2019.01370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Mateo EC, Motta FJ, Queiroz RG, Scrideli CA, Tone LG. 
Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients. J Pediatr Genet. 2012;1(3):181–187.
</cite> [<a href="https://doi.org/10.3233/PGE-2012-028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5020939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27625820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr%20Genet&amp;title=Protein%20expression%20of%20matrix%20metalloproteinase%20(MMP-1,%20-2,%20-3,%20-9%20and%20-14)%20in%20Ewing%20family%20tumors%20and%20medulloblastomas%20of%20pediatric%20patients&amp;volume=1&amp;issue=3&amp;publication_year=2012&amp;pages=181-187&amp;pmid=27625820&amp;doi=10.3233/PGE-2012-028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Zhou C, Kuang M, Tao Y, Wang J, Luo Y, Fu Y, Chen Z, Liu Y, Li Z, Wu W, et al. 
<em>Nynrin</em> preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. Cell Stem Cell. 2024;31(9):1359–1375.e8.
</cite> [<a href="https://doi.org/10.1016/j.stem.2024.06.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38955185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Stem%20Cell&amp;title=Nynrin%20preserves%20hematopoietic%20stem%20cell%20function%20by%20inhibiting%20the%20mitochondrial%20permeability%20transition%20pore%20opening&amp;volume=31&amp;issue=9&amp;publication_year=2024&amp;pages=1359-1375.e8&amp;pmid=38955185&amp;doi=10.1016/j.stem.2024.06.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Yang S, Liu Y, Wu T, Zhang X, Xu S, Pan Q, Zhu L, Zheng P, Qiao D, Zhu W. 
Synthesis and application of a novel multifunctional nanoprodrug for synergistic chemotherapy and phototherapy with hydrogen sulfide gas. J Med Chem. 2025;68(3):3197–3211.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c02426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39786725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Chem&amp;title=Synthesis%20and%20application%20of%20a%20novel%20multifunctional%20nanoprodrug%20for%20synergistic%20chemotherapy%20and%20phototherapy%20with%20hydrogen%20sulfide%20gas&amp;volume=68&amp;issue=3&amp;publication_year=2025&amp;pages=3197-3211&amp;pmid=39786725&amp;doi=10.1021/acs.jmedchem.4c02426&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Zhang S, Xiong X, Sun Y. 
Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020;5(1):
Article 135.
</cite> [<a href="https://doi.org/10.1038/s41392-020-00242-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7391717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32728033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct%20Target%20Ther&amp;title=Functional%20characterization%20of%20SOX2%20as%20an%20anticancer%20target&amp;volume=5&amp;issue=1&amp;publication_year=2020&amp;pages=Article%20135&amp;pmid=32728033&amp;doi=10.1038/s41392-020-00242-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Zhou HM, Zhang JG, Zhang X, Li Q. 
Targeting cancer stem cells for reversing therapy resistance: Mechanism, signaling, and prospective agents. Signal Transduct Target Ther. 2021;6(1):
Article 62.
</cite> [<a href="https://doi.org/10.1038/s41392-020-00430-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7884707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33589595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct%20Target%20Ther&amp;title=Targeting%20cancer%20stem%20cells%20for%20reversing%20therapy%20resistance:%20Mechanism,%20signaling,%20and%20prospective%20agents&amp;volume=6&amp;issue=1&amp;publication_year=2021&amp;pages=Article%2062&amp;pmid=33589595&amp;doi=10.1038/s41392-020-00430-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, et al. 
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nat Med. 2014;20(7):732–740.
</cite> [<a href="https://doi.org/10.1038/nm.3613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4108909/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24973920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Epigenetic%20targeting%20of%20Hedgehog%20pathway%20transcriptional%20output%20through%20BET%20bromodomain%20inhibition&amp;volume=20&amp;issue=7&amp;publication_year=2014&amp;pages=732-740&amp;pmid=24973920&amp;doi=10.1038/nm.3613&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Kumar V, McGuire T, Coulter DW, Sharp JG, Mahato RI. 
Challenges and recent advances in medulloblastoma therapy. Trends Pharmacol Sci. 2017;38(12):1061–1084.
</cite> [<a href="https://doi.org/10.1016/j.tips.2017.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29061299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Pharmacol%20Sci&amp;title=Challenges%20and%20recent%20advances%20in%20medulloblastoma%20therapy&amp;volume=38&amp;issue=12&amp;publication_year=2017&amp;pages=1061-1084&amp;pmid=29061299&amp;doi=10.1016/j.tips.2017.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Masui K, Gini B, Wykosky J, Zanca C, Mischel PS, Furnari FB, Cavenee WK. 
A tale of two approaches: Complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis. 2013;34(4):725–738.
</cite> [<a href="https://doi.org/10.1093/carcin/bgt086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3616676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23455378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=A%20tale%20of%20two%20approaches:%20Complementary%20mechanisms%20of%20cytotoxic%20and%20targeted%20therapy%20resistance%20may%20inform%20next-generation%20cancer%20treatments&amp;volume=34&amp;issue=4&amp;publication_year=2013&amp;pages=725-738&amp;pmid=23455378&amp;doi=10.1093/carcin/bgt086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Cao J, Huang D, Peppas NA. 
Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites. Adv Drug Deliv Rev. 2020;167:170–188.
</cite> [<a href="https://doi.org/10.1016/j.addr.2020.06.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32622022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Drug%20Deliv%20Rev&amp;title=Advanced%20engineered%20nanoparticulate%20platforms%20to%20address%20key%20biological%20barriers%20for%20delivering%20chemotherapeutic%20agents%20to%20target%20sites&amp;volume=167&amp;publication_year=2020&amp;pages=170-188&amp;pmid=32622022&amp;doi=10.1016/j.addr.2020.06.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Chow BW, Gu C. 
The molecular constituents of the blood–brain barrier. Trends Neurosci. 2015;38(10):598–608.
</cite> [<a href="https://doi.org/10.1016/j.tins.2015.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4597316/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26442694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Neurosci&amp;title=The%20molecular%20constituents%20of%20the%20blood%E2%80%93brain%20barrier&amp;volume=38&amp;issue=10&amp;publication_year=2015&amp;pages=598-608&amp;pmid=26442694&amp;doi=10.1016/j.tins.2015.08.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>Phoenix TN, Patmore DM, Boop S, Boulos N, Jacus MO, Patel YT, Roussel MF, Finkelstein D, Goumnerova L, Perreault S, et al. 
Medulloblastoma genotype dictates blood brain barrier phenotype. Cancer Cell. 2016;29(4):508–522.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2016.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4829447/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27050100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Medulloblastoma%20genotype%20dictates%20blood%20brain%20barrier%20phenotype&amp;volume=29&amp;issue=4&amp;publication_year=2016&amp;pages=508-522&amp;pmid=27050100&amp;doi=10.1016/j.ccell.2016.03.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Pandit R, Chen L, Götz J. 
The blood-brain barrier: Physiology and strategies for drug delivery. Adv Drug Deliv Rev. 2020;165–166:1–14.</cite> [<a href="https://doi.org/10.1016/j.addr.2019.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31790711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Drug%20Deliv%20Rev&amp;title=The%20blood-brain%20barrier:%20Physiology%20and%20strategies%20for%20drug%20delivery&amp;volume=165%E2%80%93166&amp;publication_year=2020&amp;pages=1-14&amp;pmid=31790711&amp;doi=10.1016/j.addr.2019.11.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Zhang D, Song J, Jing Z, Qin H, Wu Y, Zhou J, Zang X. 
Stimulus responsive nanocarrier for enhanced antitumor responses against hepatocellular carcinoma. Int J Nanomedicine. 2024;19:13339–13355.
</cite> [<a href="https://doi.org/10.2147/IJN.S486465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11646471/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39679249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=Stimulus%20responsive%20nanocarrier%20for%20enhanced%20antitumor%20responses%20against%20hepatocellular%20carcinoma&amp;volume=19&amp;publication_year=2024&amp;pages=13339-13355&amp;pmid=39679249&amp;doi=10.2147/IJN.S486465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>Dong Q, Jiang Z. 
Platinum–iron nanoparticles for oxygen-enhanced sonodynamic tumor cell suppression. Inorganics. 2024;12(12):
Article 331.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Inorganics&amp;title=Platinum%E2%80%93iron%20nanoparticles%20for%20oxygen-enhanced%20sonodynamic%20tumor%20cell%20suppression&amp;volume=12&amp;issue=12&amp;publication_year=2024&amp;pages=Article%20331&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Soto M, Cai W, Konishi M, Kahn CR. 
Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. Proc Natl Acad Sci USA. 2019;116(13):6379–6384.
</cite> [<a href="https://doi.org/10.1073/pnas.1817391116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6442573/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30765523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Insulin%20signaling%20in%20the%20hippocampus%20and%20amygdala%20regulates%20metabolism%20and%20neurobehavior&amp;volume=116&amp;issue=13&amp;publication_year=2019&amp;pages=6379-6384&amp;pmid=30765523&amp;doi=10.1073/pnas.1817391116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>Kariolis MS, Wells RC, Getz JA, Kwan W, Mahon CS, Tong R, Kim DJ, Srivastava A, Bedard C, Henne KR, et al. 
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med. 2020;12(545):
Article eaay1359.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aay1359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32461332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med&amp;title=Brain%20delivery%20of%20therapeutic%20proteins%20using%20an%20Fc%20fragment%20blood-brain%20barrier%20transport%20vehicle%20in%20mice%20and%20monkeys&amp;volume=12&amp;issue=545&amp;publication_year=2020&amp;pages=Article%20eaay1359&amp;pmid=32461332&amp;doi=10.1126/scitranslmed.aay1359&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ, et al. 
Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med. 2011;3(84):
Article 84ra44.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.3002230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21613623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med&amp;title=Boosting%20brain%20uptake%20of%20a%20therapeutic%20antibody%20by%20reducing%20its%20affinity%20for%20a%20transcytosis%20target&amp;volume=3&amp;issue=84&amp;publication_year=2011&amp;pages=Article%2084ra44&amp;pmid=21613623&amp;doi=10.1126/scitranslmed.3002230&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Qiao C, Yang J, Shen Q, Liu R, Li Y, Shi Y, Chen J, Shen Y, Xiao Z, Weng J, et al. 
Traceable nanoparticles with dual targeting and ROS response for RNAi-based immunochemotherapy of intracranial glioblastoma treatment. Adv Mater. 2018;30(18):
Article e1705054.
</cite> [<a href="https://doi.org/10.1002/adma.201705054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29577457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Mater&amp;title=Traceable%20nanoparticles%20with%20dual%20targeting%20and%20ROS%20response%20for%20RNAi-based%20immunochemotherapy%20of%20intracranial%20glioblastoma%20treatment&amp;volume=30&amp;issue=18&amp;publication_year=2018&amp;pages=Article%20e1705054&amp;pmid=29577457&amp;doi=10.1002/adma.201705054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>Wang Q, Kumar V, Lin F, Sethi B, Coulter DW, McGuire TR, Mahato RI. 
ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating medulloblastoma in mice. J Control Release. 2020;323:463–474.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2020.04.053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32380205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=ApoE%20mimetic%20peptide%20targeted%20nanoparticles%20carrying%20a%20BRD4%20inhibitor%20for%20treating%20medulloblastoma%20in%20mice&amp;volume=323&amp;publication_year=2020&amp;pages=463-474&amp;pmid=32380205&amp;doi=10.1016/j.jconrel.2020.04.053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>Carbonaro TM, Gatch MB. 
Neuropharmacology of <em>N</em>,<em>N</em>-dimethyltryptamine. Brain Res Bull. 2016;126(Pt 1):74–88.
</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2016.04.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5048497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27126737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Res%20Bull&amp;title=Neuropharmacology%20of%20N,N-dimethyltryptamine&amp;volume=126&amp;issue=Pt%201&amp;publication_year=2016&amp;pages=74-88&amp;pmid=27126737&amp;doi=10.1016/j.brainresbull.2016.04.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>Ma F, Yang L, Sun Z, Chen J, Rui X, Glass Z, Xu Q. 
Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci Adv. 2020;6(30):
Article eabb4429.
</cite> [<a href="https://doi.org/10.1126/sciadv.abb4429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7439549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32832671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Adv&amp;title=Neurotransmitter-derived%20lipidoids%20(NT-lipidoids)%20for%20enhanced%20brain%20delivery%20through%20intravenous%20injection&amp;volume=6&amp;issue=30&amp;publication_year=2020&amp;pages=Article%20eabb4429&amp;pmid=32832671&amp;doi=10.1126/sciadv.abb4429&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>Wang Z, Wang X, Yu H, Chen M. 
Glioma-targeted multifunctional nanoparticles to co-deliver camptothecin and curcumin for enhanced chemo-immunotherapy. Biomater Sci. 2022;10(5):1292–1303.
</cite> [<a href="https://doi.org/10.1039/d1bm01987b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35083994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater%20Sci&amp;title=Glioma-targeted%20multifunctional%20nanoparticles%20to%20co-deliver%20camptothecin%20and%20curcumin%20for%20enhanced%20chemo-immunotherapy&amp;volume=10&amp;issue=5&amp;publication_year=2022&amp;pages=1292-1303&amp;pmid=35083994&amp;doi=10.1039/d1bm01987b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, Febbo PG, Wechsler-Reya RJ. 
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell. 2009;15(2):135–147.
</cite> [<a href="https://doi.org/10.1016/j.ccr.2008.12.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2664097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19185848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Identification%20of%20CD15%20as%20a%20marker%20for%20tumor-propagating%20cells%20in%20a%20mouse%20model%20of%20medulloblastoma&amp;volume=15&amp;issue=2&amp;publication_year=2009&amp;pages=135-147&amp;pmid=19185848&amp;doi=10.1016/j.ccr.2008.12.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>Ward RJ, Lee L, Graham K, Satkunendran T, Yoshikawa K, Ling E, Harper L, Austin R, Nieuwenhuis E, Clarke ID, et al. 
Multipotent CD15<sup>+</sup> cancer stem cells in <em>Patched-1</em>-deficient mouse medulloblastoma. Cancer Res. 2009;69(11):4682–4690.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-0342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19487286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Multipotent%20CD15+%20cancer%20stem%20cells%20in%20Patched-1-deficient%20mouse%20medulloblastoma&amp;volume=69&amp;issue=11&amp;publication_year=2009&amp;pages=4682-4690&amp;pmid=19487286&amp;doi=10.1158/0008-5472.CAN-09-0342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplementary 1</span><p>Figs. S1 to S11</p>
<p>Table S1</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12332260/bin/bmr.0237.f1.docx" data-ga-action="click_feat_suppl" class="usa-link">bmr.0237.f1.docx</a><sup> (2.4MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data will be made available on request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Biomaterials Research are provided here courtesy of <strong>AAAS Science Partner Journal Program</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.34133/bmr.0237"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/bmr.0237.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (22.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332260/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332260/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332260%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332260/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332260/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332260/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40785845/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332260/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40785845/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332260/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332260/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="8ANg8rfD5IwIxWLyp3226DLCvJzWQ1ZCik7GYMLWOUWPGwuRYf2X5r2bkzyhxhCc">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
